Update on sentinel lymph node evaluation in gynecologic malignancies

Por Robison, Katina, Holman, Laura L., Moore, Richard G.
Publicado no Curr Opin Obstet Gynecol (2011)

Current state of biomarker development for clinical application in epithelial ovarian cancer

Por Moore, Richard G., MacLaughlan, Shannon, Bast, Robert C.
Publicado em 2009

DIFFERENTIAL DIAGNOSIS OF A PELVIC MASS: IMPROVED ALGORITHMS AND NOVEL BIOMARKERS

Por Bast, Robert C., Skates, Steven, Lokshin, Anna, Moore, Richard G.
Publicado em 2012

Tetrathiomolybdate sensitizes ovarian cancer cells to anticancer drugs doxorubicin, fenretinide, 5-fluorouracil and mitomycin C

Por Kim, Kyu Kwang, Lange, Thilo S, Singh, Rakesh K, Brard, Laurent, Moore, Richard G
Publicado em 2012

Organometallic Iron(III)-Salophene Exerts Cytotoxic Properties in Neuroblastoma Cells via MAPK Activation and ROS Generation

Por Kim, Kyu Kwang, Singh, Rakesh K., Strongin, Robert M., Moore, Richard G., Brard, Laurent, Lange, Thilo S.
Publicado em 2011

HE4 expression is associated with hormonal elements and mediated by importin-dependent nuclear translocation

Por Lokich, Elizabeth, Singh, Rakesh K., Han, Alex, Romano, Nicole, Yano, Naohiro, Kim, Kyukwang, Moore, Richard G.
Publicado em 2014

Spiroguanidine rhodamines as fluorogenic probes for lysophosphatidic acid

Por Wang, Lei, Sibrian-Vazquez, Martha, Escobedo, Jorge O., Wang, Jialu, Moore, Richard G., Strongin, Robert M.
Publicado no Chem Commun (Camb) (2015)

Serum Levels of the Ovarian Cancer Biomarker HE4 are decreased in Pregnancy and Increase with Age

Por Moore, Richard G., Miller, M. Craig, Eklund, Elizabeth E., Lu, Karen H., Bast, Robert C., Lambert-Messerlian, Geralyn
Publicado em 2011

Tetrathiomolybdate inhibits mitochondrial complex IV and mediates degradation of hypoxia-inducible factor-1α in cancer cells

Por Kwang Kim, Kyu, Abelman, Sarah, Yano, Naohiro, Ribeiro, Jennifer R., Singh, Rakesh K., Tipping, Marla, Moore, Richard G.
Publicado no Sci Rep (2015)

Tetrathiomolybdate mediates cisplatin-induced p38 signaling and EGFR degradation and enhances response to cisplatin therapy in gynecologic cancers

Por Kim, Kyu Kwang, Han, Alex, Yano, Naohiro, Ribeiro, Jennifer R., Lokich, Elizabeth, Singh, Rakesh K., Moore, Richard G.
Publicado no Sci Rep (2015)

Evaluation of the Diagnostic Accuracy of the Risk of Ovarian Malignancy Algorithm in Women With a Pelvic Mass

Por Moore, Richard G., Miller, M. Craig, Disilvestro, Paul, Landrum, Lisa M., Gajewski, Walter, Ball, John J., Skates, Steven J.
Publicado em 2011

Templated Polymers Enable Selective Capture and Release of Lysophosphatidic Acid in Human Plasma via Optimization of Non-Covalent Binding to Functional Monomers

Por Wang, Jialu, Sibrian-Vazquez, Martha, Escobedo, Jorge O., Wang, Lei, Chu, Yu-Hsuan, Moore, Richard G., Strongin, Robert M.
Publicado no Analyst (2015)

The cranberry flavonoids PAC DP-9 and quercetin aglycone induce cytotoxicity and cell cycle arrest and increase cisplatin sensitivity in ovarian cancer cells

Por WANG, YIFEI, HAN, ALEX, CHEN, EVA, SINGH, RAKESH K., CHICHESTER, CLINTON O., MOORE, RICHARD G., SINGH, AJAY P., VORSA, NICHOLI
Publicado no Int J Oncol (2015)

Simple enrichment and analysis of plasma lysophosphatidic acids

Por Wang, Jialu, Sibrian-Vazquez, Martha, Escobedo, Jorge O., Lowry, Mark, Wang, Lei, Chu, Yu-Hsuan, Moore, Richard G., Strongin, Robert M.
Publicado em 2013

Serum HE4 levels are less frequently elevated than CA125 in women with benign gynecologic disorders

Por Moore, Richard G., Miller, M. Craig, Steinhoff, Margaret M., Skates, Steven J., Lu, Karen H., Lambert-Messerlian, Geralyn, Bast, Robert C.
Publicado em 2011

Novel Small Molecule MEK Inhibitor URML-3881 Enhances Cisplatin Sensitivity in Clear Cell Ovarian Cancer

Por Rowswell-Turner, Rachael B., Rutishauser, Jennifer A., Kim, Kyu Kwang, Khazan, Negar, Sivagnanalingam, Umayal, Jones, Aaron M., Singh, Rakesh K., Moore, Richard G.
Publicado no Transl Oncol (2019)

Urinary Mesothelin Provides Greater Sensitivity for Early Stage Ovarian Cancer than Serum Mesothelin, Urinary hCG Free Beta Subunit and Urinary hCG Beta Core Fragment

Por Badgwell, Donna, Lu, Zhen, Cole, Laurence, Fritsche, Herbert, Atkinson, Edward N., Somers, Elizabeth, Allard, Jeffrey, Moore, Richard G., Lu, Karen H., Bast, Robert C.
Publicado em 2007

Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus

Por Moore, Richard G., Brown, Amy K., Miller, M. Craig, Badgwell, Donna, Lu, Zhen, Allard, W. Jeffrey, Granai, C.O., Bast, Robert C., Lu, Karen
Publicado em 2008

Human Epididymis Protein 4 Promotes Events Associated with Metastatic Ovarian Cancer via Regulation of the Extracelluar Matrix

Por Ribeiro, Jennifer R., Gaudet, Hilary M., Khan, Mehreen, Schorl, Christoph, James, Nicole E., Oliver, Matthew T., DiSilvestro, Paul A., Moore, Richard G., Yano, Naohiro
Publicado no Front Oncol (2018)

Comparison of a Novel Multiple Marker Assay Versus the Risk of Malignancy Index for the Prediction of Epithelial Ovarian Cancer in Patients with a Pelvic Mass

Por MOORE, Richard G., JABRE-RAUGHLEY, Moune, BROWN, Amy K., ROBISON, Katina M., MILLER, M. Craig, ALLARD, W. Jeffery, KURMAN, Robert J., BAST, Robert C., SKATES, Steven J.
Publicado em 2010